Compare Cronos Group Inc (CRON) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Oxford Lane Capital Corp — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.14B), while Oxford Lane Capital Corp trades at $9.36 (market cap $909.61M). The key difference: Cronos Group Inc is the larger of the two by market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | OXLC | |
|---|---|---|
Market Cap | $1.14B | $909.61M |
Sector | Health | Financials |
52-Week High | $3.27 | $18.75 |
52-Week Low | $2.30 | $8.15 |
Enterprise Value | $341.13M | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
